MCID: INT060
MIFTS: 42

Intestinal Atresia malady

Category: Gastrointestinal diseases

Aliases & Classifications for Intestinal Atresia

About this section

Summaries for Intestinal Atresia

About this section
Wikipedia:71 Intestinal atresia is a malformation where there is a narrowing or absence of a portion of the... more...

MalaCards based summary: Intestinal Atresia is related to peters anomaly and umbilical cord ulceration and intestinal atresia. An important gene associated with Intestinal Atresia is TTC7A (Tetratricopeptide Repeat Domain 7A), and among its related pathways are Heart Development and FOXA2 and FOXA3 transcription factor networks. Affiliated tissues include small intestine, smooth muscle and pancreas, and related mouse phenotypes are pigmentation and liver/biliary system.

Related Diseases for Intestinal Atresia

About this section

Diseases related to Intestinal Atresia via text searches within MalaCards or GeneCards Suite gene sharing:

(show top 50)    (show all 64)
idRelated DiseaseScoreTop Affiliating Genes
1peters anomaly29.3FOXC1, PAX6
2umbilical cord ulceration and intestinal atresia12.3
3pancreatic hypoplasia, intestinal atresia, and gallbladder aplasia or hypoplasia, with or without tracheoesophageal fistula11.9
4gastrointestinal defects and immunodeficiency syndrome11.8
5mitchell-riley syndrome11.5
6atresia of small intestine11.5
7jejunal atresia11.3
8ciliary dyskinesia, primary, 3110.9
9gastroschisis10.1
10scapuloperoneal syndrome, myopathic type10.1FOXC1, PITX2
11mosaic trisomy 1310.1GCK, PDX1
12distal muscular dystrophy10.1GCK, PDX1
13conjunctival folliculosis10.0FOXC1, PITX2
14cardiac arrhythmia, ankyrin-b-related10.0FOXC1, PITX2
15kcnj10-related pendred syndrome10.0FOXC1, PAX6
16non-syndromic intellectual disability10.0GCK, PDX1
17intussusception10.0
18ring dermoid of cornea9.9PAX6, PITX2
19focal segmental glomerulosclerosis 89.9GCK, PDX1
20microcephaly9.9
21aphakia, congenital primary9.9FOXC1, PAX6, PITX2
22jph2-related familial hypertrophic cardiomyopathy9.9FOXC1, PAX6, PITX2
23skin granular cell tumor9.9FOXC1, PAX6, PITX2
24cornea plana9.8FOXC1, PAX6, PITX2
25hypertrophy of breast9.8FOXC1, PAX6, PITX2
26severe combined immunodeficiency9.8
27deafness, autosomal recessive 919.8FOXC1, PAX6, PITX2
28muir-torre syndrome9.8FOXC1, PAX6, PITX2
29peritonitis9.8
30congenital stationary night blindness9.7GCK, PAX6, PDX1, RFX6
31myopia 79.7FOXC1, PAX6, PDX1, PITX2
32meconium ileus9.7
33jejunoileitis9.7
34omphalocele9.7
35imperforate anus9.7
36short bowel syndrome9.7
37intestinal obstruction9.7
38intestinal volvulus9.7
39duodenitis9.7
40frias syndrome9.5
41feingold syndrome9.5
42hemochromatosis9.5
43alagille syndrome9.5
44duodenal atresia9.5
45pulmonary hypertension9.5
46glomerulonephritis9.5
47hepatitis9.5
48umbilical hernia9.5
49thrombosis9.5
50mucositis9.5

Graphical network of the top 20 diseases related to Intestinal Atresia:



Diseases related to intestinal atresia

Symptoms & Phenotypes for Intestinal Atresia

About this section

MGI Mouse Phenotypes related to Intestinal Atresia according to GeneCards Suite gene sharing:

41
idDescriptionMGI Source AccessionScoreTop Affiliating Genes
1MP:00011869.6FOXC1, PAX6, PITX2, TTC7A
2MP:00053709.0FOXC1, GCK, PDX1, PITX2, TTC7A
3MP:00053818.7FOXC1, PAX6, PDX1, PITX2, RFX6, TTC7A
4MP:00053678.2FOXC1, GCK, PAX6, PDX1, TTC7A
5MP:00053798.1FOXC1, GCK, PAX6, PDX1, PITX2, RFX6
6MP:00053788.1FOXC1, GCK, PAX6, PDX1, PITX2, RFX6
7MP:00053768.0FOXC1, GCK, PAX6, PDX1, PITX2, RFX6
8MP:00107688.0FOXC1, GCK, PAX6, PDX1, PITX2, RFX6

Drugs & Therapeutics for Intestinal Atresia

About this section

Drugs for Intestinal Atresia (from DrugBank, HMDB, Dgidb, PharmGKB, IUPHAR, NovoSeek, BitterDB):

(show all 35)
idNameStatusPhaseClinical TrialsCas NumberPubChem Id
1
Bosentanapproved, investigationalPhase 2104147536-97-8104865
Synonyms:
-5-(o-methoxyphenoxy)-2-(2-pyrimidinyl)-4-pyrimidinyl]benzenesulfonamide
147536-97-8
174227-18-0
4-(1,1-Dimethylethyl)-N-(6-(2-hydroxyethoxy)-5-(2-methoxyphenoxy)-(2,2'-bipyrimidin)-4-yl) benzenesulfornamide
4-(1,1-Dimethylethyl)-N-(6-(2-hydroxyethoxy)-5-(2-methoxyphenoxy)-(2,2'-bipyrimidin)-4-yl)benzenesulfornamide
4-t-butyl-N-(6-(2-hydroxyethoxy)-5-(2-methoxyphenoxy)-2,2'-bipyrimidin-4-yl)benzenesulfonamide
4-tert-butyl-N-[6-(2-hydroxyethoxy)-5-(2-methoxyphenoxy)-2,2'-bipyrimidin-4-yl]benzenesulfonamide
4-tert-butyl-N-[6-(2-hydroxyethoxy)-5-(2-methoxyphenoxy)-2-pyrimidin-2-ylpyrimidin-4-yl]benzenesulfonamide
AC-148
AC1L2XN2
Actelion
Bosentan
Bosentan (INN)
Bosentan [USAN:INN:BAN]
Bosentan hydrate
C27H29N5O6S
CHEBI:51450
CHEMBL957
CID104865
D07538
DB00559
 
EN002863
HMS2090N14
I06-1873
KS-5062
L001086
LS-31532
MolPort-003-845-300
NCGC00167440-01
PDSP1_001731
PDSP2_001714
Ro 47-0203
Ro 47-0203/039
Ro-47-0203
Ro-47-0203/029
Ro-47-0203/039
TL8001039
Tracleer
UNII-XUL93R30K2
bosentan
bosentanum
bosentán
p-tert-Butyl-N-(6-(2-hydroxyethoxy)-5-(o-methoxyphenoxy)-2-(2-pyrimidinyl)-4-pyrimidinyl)benzenesulfonamide
p-tert-Butyl-N-[6-(2-hydroxyethoxy)
2Liver ExtractsPhase 24067
3Pharmaceutical SolutionsPhase 28192
4Antihypertensive AgentsPhase 24207
5Endothelin Receptor AntagonistsPhase 2218
6Parenteral Nutrition SolutionsPhase 2160
7Protective AgentsPhase 27443
8Fat Emulsions, IntravenousPhase 297
9AntioxidantsPhase 23050
10
BilirubinPhase 2116635-65-45280352
Synonyms:
(4Z,15Z)-Bilirubin IXa
(Z,Z)-Bilirubin IXa
1,10,19,22,23,24-Hexahydro-2,7,13,17-tetramethyl-1,19-dioxo-3,18-divinyl-Biline-8,12-dipropionate
1,10,19,22,23,24-Hexahydro-2,7,13,17-tetramethyl-1,19-dioxo-3,18-divinyl-Biline-8,12-dipropionic acid
2,17-Diethenyl-1,10,19,22,23,24-hexahydro-3,7,13,18-tetramethyl-1,19-dioxo-21H-Biline-8,12-dipropanoate
2,17-Diethenyl-1,10,19,22,23,24-hexahydro-3,7,13,18-tetramethyl-1,19-dioxo-21H-Biline-8,12-dipropanoic acid
3-(2-((3-(2-Carboxyethyl)-4-methyl-5-((3-methyl-5-oxo-4-vinyl-1,5-dihydro-2H-pyrrol-2-ylidene)methyl)-1H-pyrrol-2-yl)methyl)-4-methyl-5-((4-methyl-5-oxo-3-vinyl-1,5-dihydro-2H-pyrrol-2-ylidene)methyl)-1H-pyrrol-3-yl)propanoate
3-(2-((3-(2-Carboxyethyl)-4-methyl-5-((3-methyl-5-oxo-4-vinyl-1,5-dihydro-2H-pyrrol-2-ylidene)methyl)-1H-pyrrol-2-yl)methyl)-4-methyl-5-((4-methyl-5-oxo-3-vinyl-1,5-dihydro-2H-pyrrol-2-ylidene)methyl)-1H-pyrrol-3-yl)propanoic acid
 
3-(2-((3-(2-Carboxyethyl)-4-methyl-5-[(Z)-(3-methyl-5-oxo-4-vinyl-1,5-dihydro-2H-pyrrol-2-ylidene)methyl]-1H-pyrrol-2-yl)methyl)-4-methyl-5-[(Z)-(4-methyl-5-oxo-3-vinyl-1,5-dihydro-2H-pyrrol-2-ylidene
3-[2-[[3-(2-Carboxyethyl)-5-[(3-ethenyl-4-methyl-5-oxo-pyrrol-2-ylidene)methyl]-4-methyl-1H-pyrrol-2-yl]methyl]-5-[(4-ethenyl-3-methyl-5-oxo-pyrrol-2-ylidene)methyl]-4-methyl-1H-pyrrol-3-yl]propanoate
3-[2-[[3-(2-Carboxyethyl)-5-[(3-ethenyl-4-methyl-5-oxo-pyrrol-2-ylidene)methyl]-4-methyl-1H-pyrrol-2-yl]methyl]-5-[(4-ethenyl-3-methyl-5-oxo-pyrrol-2-ylidene)methyl]-4-methyl-1H-pyrrol-3-yl]propanoic acid
3-[2-[[3-(2-Carboxyethyl)-5-[(Z)-(3-ethenyl-4-methyl-5-oxo-pyrrol-2-ylidene)methyl]-4-methyl-1H-pyrrol-2-yl]methyl]-5-[(Z)-(4-ethenyl-3-methyl-5-oxo-pyrrol-2-ylidene)methyl]-4-methyl-1H-pyrrol-3-yl]propanoate
3-[2-[[3-(2-Carboxyethyl)-5-[(Z)-(3-ethenyl-4-methyl-5-oxo-pyrrol-2-ylidene)methyl]-4-methyl-1H-pyrrol-2-yl]methyl]-5-[(Z)-(4-ethenyl-3-methyl-5-oxo-pyrrol-2-ylidene)methyl]-4-methyl-1H-pyrrol-3-yl]propanoic acid
Bilirubin
Bilirubin IX-alpha
Cholerythrin
Hematoidin
11Soybean oil, phospholipid emulsionPhase 276
12Hormone AntagonistsPhase 1, Phase 213180
13IncretinsPhase 1, Phase 21579
14Glucagon-Like Peptide 1Phase 1, Phase 2715
15Hormones, Hormone Substitutes, and Hormone AntagonistsPhase 1, Phase 213168
16HormonesPhase 1, Phase 214415
17glucagonPhase 1, Phase 2478
18Gastrointestinal AgentsPhase 1, Phase 28402
19Omega 3 Fatty AcidNutraceuticalPhase 21018
20Soy BeanNutraceuticalPhase 2554
21
VancomycinapprovedPhase 13321404-90-6441141, 14969
Synonyms:
(1S,2R,18R,22S,25R,28R,40S)-22-(2-amino-2-Oxoethyl)-48-[2-O-(3-amino-2,3,6-trideoxy-3-methyl-alpha-L-lyxo-hexopyranosyl)-beta-D-glucopyranosyloxy]-5,15-dichloro-2,18,32,35,37-pentahydroxy-19-[(N-methyl-D-leucyl)amino]-20,23,26,42,44-pentaoxo-7,13-dioxa-21,24,27,41,43-pentaazaoctacyclo[26.14.2.2(3,6).2(14,17).1(8,12).1(29,33).0(10,25).0(34,39)]pentaconta-3,5,8(48),9,11,14,16,29(45),30,32,34,36,38,46,49-pentadecaene-40-carboxylic acid
(2.2Sp,3.5sa,2.6sp)-O(4.2),C(3.4):c(5.4),O(4.6):c(3.5),C(2.7)-tricyclo[N-methyl-D-leucyl-3-chloro-(R)-beta-hydroxy-D-tyrosyl-L-asparaginyl-D-2-(4-{[2-O-(3-amino-2,3,6-trideoxy-3-C-methyl-alpha-L-lyxo-hexopyranosyl)-beta-D-glucopyranosyl]oxy}phenyl)glycyl-D-2-(4-hydroxyphenyl)glycyl-3-chloro-(R)-beta-hydroxy-L-tyrosyl-L-2-(3,5-dihydroxyphenyl)glycine]
1404-90-6
1404-93-9 (hydrochloride)
64685-75-2 (sulfate)
AC1L24VU
AC1L9AMI
AC1Q29OH
BIDD:GT0353
C06689
C66H75Cl2N9O24
CHEBI:28001
CHEMBL262777
CID14969
CID441141
CID5311496
CID6426898
CID6917992
D00212
DB00512
EINECS 215-772-6
HSDB 3262
LMPK14000004
 
LS-161387
Lopac0_001267
MolPort-001-794-649
NCGC00162383-02
Prestwick0_000497
Prestwick1_000497
Prestwick2_000497
SPBio_002314
UNII-6Q205EH1VU
VAN
VANCOMYCIN
Vancocin
Vancocin (TN)
Vancocin HCL
Vancomicina
Vancomicina [INN-Spanish]
Vancomycin
Vancomycin (USP)
Vancomycin HCL
Vancomycin [USAN:INN:BAN]
Vancomycine
Vancomycine [INN-French]
Vancomycinum
Vancomycinum [INN-Latin]
nchembio.350-comp1
22Anti-Bacterial AgentsPhase 111226
23Anti-Infective AgentsPhase 122062
24
Neomycinapproved, vet_approved501404-04-28378
Synonyms:
(1R,2R,3S,4R,6S)-4,6-diamino-2-{[3-O-(2,6-diamino-2,6-dideoxy-beta-L-idopyranosyl)-beta-D-ribofuranosyl]oxy}-3-hydroxycyclohexyl 2,6-diamino-2,6-dideoxy-alpha-D-glucopyranoside
(2R,3S,4R,5R,6R)-5-amino-2-(aminomethyl)-6-[(1R,2R,3S,4R,6S)-4,6-diamino-2-[(2S,3R,4S,5R)-4-[(2R,3R,4R,5S,6S)-3-amino-6-(aminomethyl)-4,5-dihydroxyoxan-2-yl]oxy-3-hydroxy-5-(hydroxymethyl)oxolan-2-yl]oxy-3-hydroxycyclohexyl]oxyoxane-3,4-diol
11025-81-3
119-04-0
1393-86-8
1404-04-2
1405-10-3 (sulfate (salt))
4-18-00-07476 (Beilstein Handbook Reference)
72131_FLUKA
AB00443887
AC1L1QVH
Actilin
Actiline
Antibiotic 10676
Antibiotic produced by Streptomyces decaris. Neomycin B
Antibiotique
BDG-(1-4)CYY-(5-1)RIB-(3-1)IDG
BDG-(1-4)NEB-(5-1)RIB-(3-1)NED
BPBio1_000326
BRN 0101621
BSPBio_000296
C01737
C23H46N6O13
C25H50N6O13
CCRIS 5462
CHEBI:7508
CID8378
Caswell No. 595
D-Streptamine, O-2,6-diamino-2,6-dideoxy-.beta.-L-idopyranosyl-(1.->3)-O-.beta.-D-ribofuranosyl-(1->5)]-O-[2,6-diamino-2,6-dideoxy-.alpha.-D-glucopyranosyl-(1->4)]-2-deoxy
D05140
DB00452
DB00994
EINECS 204-292-2
EINECS 215-766-3
EPA Pesticide Chemical Code 006303
Endomixin
Enterfram
Fradiomycin
Fradiomycin B
Fradiomycinum
Framicetina
Framicetina [INN-Spanish]
Framycetin
Framycetin (INN)
Framycetin [INN:BAN:DCF]
Framycetine
Framycetine [INN-French]
Framycetinum
Framycetinum [INN-Latin]
 
Framygen
Fraquinol
HMS2089P15
HSDB 3242
LS-96091
LS-96095
MolPort-003-938-736
Myacine
Myacyne
Mycifradin
Myciguent
N1142_SIGMA
NCGC00179612-01
NEOMYCIN AND POLYMYXIN B SULFATES
NEOMYCIN B
NEOMYCIN SULFATE
NMY
Neo-Fradin
Neo-Rx
Neobiotic
Neobrettin
Neolate
Neomas
Neomcin
Neomicina
Neomicina [DCIT]
Neomin
Neomycin B Sulfate
Neomycin B sulfate
Neomycin Sulfate
Neomycin Sulphate
Neomycin solution
Neomycine
Neomycine [INN-French]
Neomycinum
Neomycinum [INN-Latin]
Nivemycin
PIMAVECORT
Prestwick3_000158
ST075177
Soframycin
Soframycin Ophthalmic
Soframycine
Tuttomycin
UNII-4BOC774388
UNII-I16QD7X297
USAF CB-19
VONAMYCIN
Vonamycin powder V
neomycin
25Vitamins5282
26Trace Elements6001
27Micronutrients6001
28Alpha 1-Antitrypsin100
29Protein C Inhibitor98
30Bile Acids and Salts106
31glutamineNutraceutical162
32AcidophilusNutraceutical558
33lysineNutraceutical98
34alanineNutraceutical132
35ColaNutraceutical1946

Interventional clinical trials:

(show all 19)
idNameStatusNCT IDPhase
1Study of Placebo or Bosentan to Treat Patients With Single Ventricle Physiology.CompletedNCT01292551Phase 2
2Compassionate Use of Omegaven in ChildrenRecruitingNCT02370251Phase 2
3Safety and Dosing Study of Glucagon-like Peptide 2 (GLP-2) in Infants and Children With Intestinal FailureTerminatedNCT01573286Phase 1, Phase 2
4Gastrointestinal Microbiota in Primary Sclerosing Cholangitis and Biliary Atresia With VancomycinCompletedNCT01322386Phase 1
5Treating Primary Sclerosing Cholangitis and Biliary Atresia With VancomycinRecruitingNCT02137668Phase 1
6Determination of Lysine Requirement in the Parenterally Fed NeonateCompletedNCT00779753
7Esophageal Atresia: Metaplasia, BarrettCompletedNCT02495051
8Use of Probiotics to Prevent Cholangitis in Children With Biliary Atresia After the Kasai PortoenterostomyCompletedNCT00166868
9Modified Perfusion for Neonatal Aortic Arch ReconstructionCompletedNCT00490256
10Survival With Own Liver of Conventional Versus Laparoscopic Kasai for Biliary AtresiaCompletedNCT01063699
11Enteral Glutamine in Reducing Bloodstream Infections in Short Bowel Syndrome InfantsCompletedNCT01576003
12Trail to Investigate the Effectiveness of CoSeal in Reducing Adhesions Following the Kasai Hepatoportoenterostomy for Biliary AtresiaRecruitingNCT01745991
13Evaluating the Genetic Causes and Progression of Cholestatic Liver Diseases (LOGIC)RecruitingNCT00571272
14Innovative Approaches to Assessment of Pain Control and Sedation in the NICURecruitingNCT03057782
153D High Resolution Anorectal Manometry in Children After Surgery for Anorectal DisordersRecruitingNCT02296008
16Molecular Genetics of Heterotaxy and Related Congenital Heart DefectsRecruitingNCT02432079
17Omegaven for Compassionate Use in the Treatment of Parenteral Nutrition-Associated Liver DiseaseAvailableNCT03072667
18Long-term Outcome in Patients With Anorectal MalformationsNot yet recruitingNCT02624232
19Prevention of Parenteral Nutrition-Associated Cholestasis With Cyclic Parenteral Nutrition in InfantsTerminatedNCT01062815

Search NIH Clinical Center for Intestinal Atresia


Cochrane evidence based reviews: intestinal atresia

Genetic Tests for Intestinal Atresia

About this section

Genetic tests related to Intestinal Atresia:

id Genetic test Affiliating Genes
1 Intestinal Atresia27

Anatomical Context for Intestinal Atresia

About this section

MalaCards organs/tissues related to Intestinal Atresia:

36
Small intestine, Smooth muscle, Pancreas, Colon, Brain, Testes, Skin

Publications for Intestinal Atresia

About this section

Articles related to Intestinal Atresia:

(show top 50)    (show all 237)
idTitleAuthorsYear
1
Role of intraluminal bowel echogenicity on prenatal ultrasounds to determine the anatomical level of intestinal atresia. (27023781)
2016
2
Intestinal Atresia: Experience at a Busy Center of North-West India. (27896159)
2016
3
Impact of hospital transfer on surgical outcomes of intestinal atresia. (27890332)
2016
4
Gallbladder Duplication Associated with Gastro-Intestinal Atresia. (27123398)
2016
5
Alagille syndrome associated with intestinal atresia. (26596367)
2016
6
Histomorphological Features of Intestinal Atresia and its Clinical Correlation. (26674207)
2015
7
Correction: the complex surgical management of the first case of severe combined immunodeficiency and multiple intestinal atresias surviving after the fourth year of life. (25866737)
2015
8
MicroRNA-211 causes ganglion cell dysplasia in congenital intestinal atresia via down-regulation of glial-derived neurotrophic factor. (26510977)
2015
9
Population-based study of esophageal and small intestinal atresia/stenosis. (24730728)
2014
10
The complex surgical management of the first case of severe combined immunodeficiency and multiple intestinal atresias surviving after the fourth year of life. (25587526)
2014
11
Multiple intestinal atresia with combined immune deficiency. (25268403)
2014
12
Tetratricopeptide repeat domain 7A (TTC7A) mutation in a newborn with multiple intestinal atresia and combined immunodeficiency. (24931897)
2014
13
Multiple intestinal atresia with combined immune deficiency related to TTC7A defect is a multiorgan pathology: study of a French-Canadian-based cohort. (25546680)
2014
14
Prolonged feeding difficulties after surgical correction of intestinal atresia: a 13-year experience. (25475800)
2014
15
Compound heterozygous mutations in TTC7A cause familial multiple intestinal atresias and severe combined immunodeficiency. (25534311)
2014
16
Ascites, anemia and (intestinal) atresia. (24374868)
2014
17
Prenatal intestinal obstruction affects the myenteric plexus and causes functional bowel impairment in fetal rat experimental model of intestinal atresia. (23667464)
2013
18
Considering the vascular hypothesis for the pathogenesis of small intestinal atresia: a case control study of genetic factors. (23444056)
2013
19
Outcomes of early versus late intestinal operations in patients with gastroschisis and intestinal atresia: results from a prospective national database. (24094951)
2013
20
Intestinal atresia occurring in association with placental fetal thrombotic vasculopathy: a case report with literature review. (22989172)
2013
21
Associated type IIIB and type IV multiple intestinal atresia in a pediatric patient. (23790793)
2013
22
What is Our Development Progress for the Treatment Outcome of Newborn with Intestinal Atresia and Stenosis in a Period of 28 Years? (23641378)
2013
23
Meconium peritonitis with intestinal atresia mimicking huge tumor in a preterm neonate. (23026488)
2013
24
Gastroschisis associated with an omphalocele and intestinal atresia. (23917330)
2013
25
Fetal MRI of hereditary multiple intestinal atresia with postnatal correlation. (24096803)
2013
26
Apple-peel intestinal atresia: enteroplasty for intestinal lengthening and primary anastomosis. (23845656)
2013
27
The clinical significance of pathological studies of congenital intestinal atresia. (24094962)
2013
28
Brown bowel syndrome: a rare and often overlooked complication of intestinal atresia. (24404548)
2013
29
The use of multiple serial transverse enteroplasty (STEP) procedures for the management of intestinal atresia and short bowel syndrome. (23896253)
2013
30
Long-term outcomes for infants with intestinal atresia studied at Children's National Medical Center. (23666458)
2013
31
Whole-exome sequencing identifies tetratricopeptide repeat domain 7A (TTC7A) mutations for combined immunodeficiency with intestinal atresias. (23830146)
2013
32
Exome sequencing identifies mutations in the gene TTC7A in French-Canadian cases with hereditary multiple intestinal atresia. (23423984)
2013
33
Epidemiology of small intestinal atresia in Europe: a register-based study. (22933095)
2012
34
Gastroschisis with intestinal atresia--predictive value of antenatal diagnosis and outcome of postnatal treatment. (22325384)
2012
35
Multiple intestinal anastomoses to avoid short bowel syndrome and stimulate bowel maturity in type IV multiple intestinal atresia and necrotizing enterocolitis. (22424368)
2012
36
Laparoscopy-assisted surgery for neonatal intestinal atresia and stenosis: a report of 35 cases. (23143134)
2012
37
Type IV intestinal atresia, congenital bilateral perisylvian syndrome, and chronic pulmonary hypertension secondary to multiple vascular disruption syndrome in a monochorionic twin. (23084212)
2012
38
Pre-natal Ultrasonographic Diagnosis of Cystic Meconium Peritonitis with Intestinal Atresia and Its Post-natal Management. (24293871)
2012
39
Early colonization of intestinal bifidobacteria and lactobacilli in the postoperative neonates with congenital intestinal atresia. (21384062)
2011
40
Intestinal atresia and ectopia in a bovine fetus. (20926733)
2011
41
Multiple intestinal atresias associated with angiodysplasia in a newborn. (21763851)
2011
42
Concordant intestinal atresia in two pairs of monozygotic twins. (23705091)
2011
43
Comparative outcomes in intestinal atresia: a clinical outcome and pathophysiology analysis. (20820789)
2011
44
Hereditary multiple intestinal atresia (HMIA) with severe combined immunodeficiency (SCID): a case report of two siblings and review of the literature on MIA, HMIA and HMIA with immunodeficiency over the last 50 years. (22715199)
2011
45
Laparoscopy-assisted surgery for neonatal intestinal atresia: single-center experience(*). (22776229)
2011
46
Medical management of motility disorders in patients with intestinal failure: a focus on necrotizing enterocolitis, gastroschisis, and intestinal atresia. (21843732)
2011
47
Intestinal atresia in association with gastroschisis: a 26-year review. (20676892)
2010
48
Balloon dilatation of postoperative small bowel anastomotic stricture in an infant with apple peel intestinal atresia after serial transverse enteroplasty and jejunoileal anastomosis. (21129527)
2010
49
Multiple intestinal atresia and congenital bilateral perisylvian syndrome in a surviving monochorionic twin with intrauterine death of the co-twin. (20713201)
2010
50
Neonatal hemochromatosis and Martinez-Frias syndrome of intestinal atresia and diabetes mellitus in a consanguineous newborn. (19887127)
2010

Variations for Intestinal Atresia

About this section

Expression for genes affiliated with Intestinal Atresia

About this section
Search GEO for disease gene expression data for Intestinal Atresia.

Pathways for genes affiliated with Intestinal Atresia

About this section

GO Terms for genes affiliated with Intestinal Atresia

About this section

Biological processes related to Intestinal Atresia according to GeneCards Suite gene sharing:

(show all 25)
idNameGO IDScoreTop Affiliating Genes
1odontogenesis of dentin-containing toothGO:004247510.4FOXC1, PITX2
2blood vessel developmentGO:000156810.4FOXC1, PAX6
3eye developmentGO:000165410.4FOXC1, PAX6
4lacrimal gland developmentGO:003280810.4FOXC1, PAX6
5iris morphogenesisGO:006107210.4PAX6, PITX2
6pituitary gland developmentGO:002198310.4PAX6, PITX2
7regulation of cell migrationGO:003033410.3PAX6, PITX2
8endocrine pancreas developmentGO:003101810.2PDX1, RFX6
9positive regulation of insulin secretion involved in cellular response to glucose stimulusGO:003577410.2PDX1, RFX6
10response to woundingGO:000961110.2PAX6, PDX1
11smoothened signaling pathwayGO:000722410.2PAX6, PDX1
12detection of glucoseGO:005159410.1GCK, PDX1
13glucose metabolic processGO:000600610.1GCK, PDX1
14positive regulation of insulin secretionGO:003202410.1GCK, PDX1
15brain developmentGO:000742010.0FOXC1, PAX6, PITX2
16camera-type eye developmentGO:004301010.0FOXC1, PAX6, PITX2
17regulation of insulin secretionGO:005079610.0GCK, RFX6
18positive regulation of DNA bindingGO:00433889.9FOXC1, PDX1, PITX2
19animal organ morphogenesisGO:00098879.9PAX6, PDX1, PITX2
20multicellular organism developmentGO:00072759.3PAX6, PDX1, PITX2, RFX6
21glucose homeostasisGO:00425939.1GCK, PAX6, PDX1, RFX6
22type B pancreatic cell differentiationGO:00033099.0PAX6, PDX1, RFX6
23positive regulation of transcription from RNA polymerase II promoterGO:00459448.9FOXC1, PAX6, PDX1, PITX2, RFX6
24positive regulation of transcription, DNA-templatedGO:00458938.9FOXC1, PAX6, PDX1, PITX2, RFX6
25transcription from RNA polymerase II promoterGO:00063668.4FOXC1, PAX6, PDX1, PITX2, RFX6

Molecular functions related to Intestinal Atresia according to GeneCards Suite gene sharing:

(show all 10)
idNameGO IDScoreTop Affiliating Genes
1transcription factor activity, RNA polymerase II distal enhancer sequence-specific bindingGO:000370510.3FOXC1, PDX1
2RNA polymerase II transcription factor activity, sequence-specific DNA bindingGO:000098110.0FOXC1, PAX6, PITX2
3chromatin bindingGO:00036829.9PAX6, PDX1, PITX2
4transcription regulatory region DNA bindingGO:00442129.7FOXC1, PAX6, RFX6
5sequence-specific DNA bindingGO:00435659.4FOXC1, PAX6, PDX1, PITX2
6transcription factor activity, sequence-specific DNA bindingGO:00037009.4FOXC1, PAX6, PDX1, PITX2
7transcription factor bindingGO:00081349.3FOXC1, PAX6, PDX1, PITX2
8RNA polymerase II core promoter proximal region sequence-specific DNA bindingGO:00009789.3PAX6, PDX1, PITX2, RFX6
9transcriptional activator activity, RNA polymerase II transcription regulatory region sequence-specific bindingGO:00012289.1FOXC1, PAX6, RFX6
10DNA bindingGO:00036779.0FOXC1, PAX6, PDX1, PITX2, RFX6

Sources for Intestinal Atresia

About this section
2CDC
6CNVD
10DGIdb
15ExPASy
16FDA
17FMA
27GTR
28HGMD
29HMDB
30ICD10
31ICD10 via Orphanet
32ICD9CM
33IUPHAR
34KEGG
37MedGen
39MeSH
40MESH via Orphanet
41MGI
44NCI
45NCIt
46NDF-RT
49NINDS
50Novoseek
52OMIM
53OMIM via Orphanet
57PubMed
58QIAGEN
63SNOMED-CT via Orphanet
67Tumor Gene Family of Databases
68UMLS
69UMLS via Orphanet